The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has made two awards totaling $153 million to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The awards were announced today by U.S. Secretary of Commerce Gina Raimondo at the NIIMBL annual meeting in Washington, D.C.

NIIMBL...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute, announced that the University of Delaware, on behalf of NIIMBL, has entered into a Collaborative Research and Development Agreement (CRADA) with the Food and Drug Administration (FDA). Effective July 15, 2019, the FDA and NIIMBL will...

The mission of the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute, is to accelerate biopharmaceutical manufacturing innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical...

Dr. Francis Collins is one of the world’s pre-eminent scientists, having directed the extraordinary international Human Genome Project that mapped out humanity’s genes for the first time. He has been elected to the National Academy of Medicine and the National Academy of Sciences and has received the Presidential Medal of Freedom and the National...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute, announces a grant to help fund the advancement of biopharmaceutical manufacturing technology in the U.S. and globally from the Bill & Melinda Gates Foundation.

NIIMBL will receive up to $1.5M from the foundation to support the...